Kevin Hakimi
Overview
Explore the profile of Kevin Hakimi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Puri D, Saitta C, Liu F, Afari J, Meagher M, et al.
Eur Urol Open Sci
. 2025 Jan;
71:96-105.
PMID: 39758852
Background And Objective: Our aim was to determine the clinical characteristics, temporal trends, and survival outcomes for sarcomatoid-dedifferentiated renal cell carcinoma (sRCC), as sRCC has historically had poor prognosis and...
2.
Tuderti G, Mastroianni R, Proietti F, Wu Z, Wang L, Franco A, et al.
World J Urol
. 2024 Nov;
42(1):641.
PMID: 39556201
No abstract available.
3.
Saitta C, Garofano G, Afari J, Tanaka H, Patil D, Yuen K, et al.
Clin Genitourin Cancer
. 2024 Oct;
22(6):102232.
PMID: 39481317
Objective: We sought to develop a preoperative nomogram called NODESAFE (NODE SAFEty) to predict nodal involvement (NI) at time of surgery or subsequent follow up in localized renal cell carcinoma...
4.
Tuderti G, Mastroianni R, Proietti F, Wu Z, Wang L, Franco A, et al.
World J Urol
. 2024 Oct;
42(1):575.
PMID: 39395052
Purpose: To assess the impact of neoadjuvant and adjuvant chemotherapy on survival outcomes, within a large multicenter cohort of Upper tract urothelial carcinoma patients treated with Nephroureterectomy. Methods: A multicenter...
5.
Zappia J, Yong C, Slaven J, Wu Z, Wang L, Djaladat H, et al.
Clin Genitourin Cancer
. 2024 Sep;
22(6):102220.
PMID: 39332082
Objective: Discrepancies in survival outcomes of various genitourinary tract malignancies have been documented across different racial and ethnic groups. Here we sought to examine long-term survival outcomes of patients with...
6.
Hemal S, Sobhani S, Hakimi K, Rosenberg S, Gill I
Int Braz J Urol
. 2024 Aug;
50(5):659-660.
PMID: 39106120
Objective: We present a novel technique to perform single-port (SP) robot-assisted partial cystectomy with excision of the urachal remnant and bilateral pelvic lymph node dissection for urachal adenocarcinoma (1-7). Materials...
7.
Liu F, Wang L, Meagher M, Afari J, Saitta C, Dhanji S, et al.
Urol Oncol
. 2024 Jun;
42(10):333.e21-333.e31.
PMID: 38926077
Objective: Stage migration in renal cell carcinoma (RCC) has led to an increasing proportion of diagnosed small renal masses. Emerging knowledge regarding heterogeneity of RCC histologies and consequent impact on...
8.
Saitta C, Afari J, Patil D, Tanaka H, Yuen K, Wang L, et al.
Clin Genitourin Cancer
. 2024 May;
22(3):102098.
PMID: 38733897
Background: To evaluate relationship between histological subtypes of renal cell carcinoma (RCC) and preoperative c-reactive protein (CRP). Patients And Methods: We queried the International Marker Consortium for Renal Cancer database...
9.
Saitta C, Afari J, Walia A, Patil D, Tanaka H, Hakimi K, et al.
Urol Oncol
. 2024 Feb;
42(4):119.e1-119.e16.
PMID: 38341362
Objective: To investigate impact of body mass index (BMI) on survival across different histologies and stages of renal cell carcinoma (RCC). Methods: We conducted a retrospective multicenter analysis of clear...
10.
Hakimi K, Campbell S, Nguyen M, Rathi N, Wang L, Meagher M, et al.
BJU Int
. 2023 Nov;
133(4):425-431.
PMID: 37916303
Objective: To report the results of PADRES (Prior Axitinib as a Determinant of Outcome of Renal Surgery, NCT03438708), a study investigating neoadjuvant axitinib for tumours of high complexity with imperative...